Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low HDL-c”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)Study completedNCT01105975
What this trial is testing

LY2484595 in Patients With High LDL-C or Low HDL-C

Who this might be right for
Dyslipidemia
Eli Lilly and Company 398
Post-approval studies (Phase 4)Study completedNCT01896037
What this trial is testing

Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels

Who this might be right for
Spinal Cord InjuryTetraplegiaQuadraplegia+2 more
University of Manitoba 21
Testing effectiveness (Phase 2)Study completedNCT02585869
What this trial is testing

Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides

Who this might be right for
HypercholesterolemiaHypertriglyceridemia
NeuroBo Pharmaceuticals Inc. 161
Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00697203
What this trial is testing

Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)

Who this might be right for
Dyslipidemia
Hoffmann-La Roche 292
Post-approval studies (Phase 4)UnknownNCT00736463
What this trial is testing

Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)

Who this might be right for
HDL Cholesterol
Oregon Health and Science University 80
Large-scale testing (Phase 3)Ended earlyNCT01414166
What this trial is testing

Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)

Who this might be right for
Dyslipidemia
Merck Sharp & Dohme LLC 244
Early research (Phase 1)Study completedNCT01448824
What this trial is testing

LY2484595 on Pharmacokinetics in Healthy Participants

Who this might be right for
Healthy Participants
Eli Lilly and Company 82
Large-scale testing (Phase 3)Study completedNCT04998981
What this trial is testing

Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

Who this might be right for
Hyperlipidemia
Kowa Company, Ltd. 353
Large-scale testing (Phase 3)Study completedNCT00082251
What this trial is testing

Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST

Who this might be right for
Hypercholesterolemia
Kos Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00327002
What this trial is testing

A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism

Who this might be right for
Metabolic Syndrome X
University of Pennsylvania 40
Testing effectiveness (Phase 2)Study completedNCT01423188
What this trial is testing

The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation

Who this might be right for
Coronary Artery DiseaseDyslipidemia
Resverlogix Corp 176
Large-scale testing (Phase 3)Study completedNCT00389896
What this trial is testing

A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

Who this might be right for
HDL Cholesterol
Organon and Co 150
Not applicableStudy completedNCT01245738
What this trial is testing

Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)

Who this might be right for
DyslipidemiasHypercholesterolemiaHypertriglyceridemia+2 more
Merck Sharp & Dohme LLC 635
Post-approval studies (Phase 4)Ended earlyNCT01025492
What this trial is testing

Study of Trilipix Effects on Lipids and Arteries

Who this might be right for
Dyslipidemia
University of Utah 24
Large-scale testing (Phase 3)Study completedNCT01860729
What this trial is testing

The Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)

Who this might be right for
Hypercholesterolemia
Merck Sharp & Dohme LLC 589
Large-scale testing (Phase 3)Study completedNCT05079919
What this trial is testing

Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia

Who this might be right for
Severe Hypertriglyceridemia
Ionis Pharmaceuticals, Inc. 617
Post-approval studies (Phase 4)Ended earlyNCT01308203
What this trial is testing

Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease

Who this might be right for
Coronary Artery DiseaseDyslipidemias
Daniel A. Siniawski 32
Early research (Phase 1)Study completedNCT01618916
What this trial is testing

LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 51
Large-scale testing (Phase 3)Study completedNCT01717300
What this trial is testing

The Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021)

Who this might be right for
Hypercholesterolemia
Merck Sharp & Dohme LLC 459
Load More Results